We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

119 hedge funds and large institutions have $341M invested in Spectrum Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

13% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 38

3% more funds holding

Funds holding: 115119 (+4)

10% less capital invested

Capital invested by funds: $377M → $341M (-$36.6M)

63% less call options, than puts

Call options by funds: $1.08M | Put options by funds: $2.91M

Holders
119
Holders Change
+4
Holders Change %
+3.48%
% of All Funds
3.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
43
Reduced
38
Closed
14
Calls
$1.08M
Puts
$2.91M
Net Calls
-$1.83M
Net Calls Change
-$87K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$2.22M +$312K +36,888 +15%
Macquarie Group
27
Macquarie Group
Australia
$2.19M +$619K +73,140 +35%
BA
28
Bard Associates
Illinois
$1.99M -$2.62K -310 -0.1%
BIM
29
BlackRock Investment Management
Delaware
$1.93M +$29.5K +3,485 +1%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$1.76M
Ameriprise
31
Ameriprise
Minnesota
$1.74M +$72.8K +8,600 +4%
PAM
32
Panagora Asset Management
Massachusetts
$1.56M +$653K +77,176 +63%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.39M
PP
34
PDT Partners
New York
$1.38M
Invesco
35
Invesco
Georgia
$1.37M +$259K +30,547 +21%
Renaissance Technologies
36
Renaissance Technologies
New York
$1.34M +$861K +101,790 +146%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$1.27M -$1.13M -133,021 -45%
Charles Schwab
38
Charles Schwab
California
$1.22M +$27.4K +3,240 +2%
ARTA
39
A.R.T. Advisors
New York
$1.08M +$233K +27,506 +25%
U
40
UBS
Switzerland
$1.03M -$285K -33,669 -20%
STC
41
SEI Trust Company
Pennsylvania
$1.02M +$1.1M +130,478 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$942K
Prudential Financial
43
Prudential Financial
New Jersey
$937K +$7.62K +900 +0.8%
BG
44
BlackRock Group
United Kingdom
$912K +$39.6K +4,681 +4%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$902K +$5.08K +600 +0.5%
ProShare Advisors
46
ProShare Advisors
Maryland
$896K +$684K +80,811 +242%
Public Sector Pension Investment Board (PSP Investments)
47
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$868K -$169K -20,000 -15%
CS
48
Credit Suisse
Switzerland
$854K -$315K -37,277 -25%
AllianceBernstein
49
AllianceBernstein
Tennessee
$839K -$322 -38 -0%
Wells Fargo
50
Wells Fargo
California
$812K +$142K +16,800 +19%

SPPI Hedge Fund Activity: Q1 2014 in Review

119 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2014, worth a combined $341M — down 9.7% from $377M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SPPI positions and 14 closed out — a net gain of 4 holders — while 43 added to existing stakes and 38 trimmed.

The largest buyer was Federated Hermes, opening a new position worth an estimated $8.72M. The largest seller was Fidelity Investments, cutting an estimated $12.3M.

  • 119 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2014, up from 115 in Q4 2013.
  • Funds reported $341M of Spectrum Pharmaceuticals Inc stock for Q1 2014, down 9.7% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2014 and 14 closed out, a net change of +4 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2014 was Federated Hermes, an estimated $8.72M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2014 was Fidelity Investments, an estimated $12.3M sold.

Based on aggregated 13F filings for Q1 2014.